You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Panitumumab

Showing 1 - 25 of 316
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (biological, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Panitumumab
  • +9 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jun 4, 2023

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Panitumumab
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 16, 2023

Efficacy Trial in Seoul (Oral sotorasib + IV Panitumumab)

Active, not recruiting
  • Efficacy
  • Oral sotorasib + IV Panitumumab
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Aug 14, 2023

Metastatic Colorectal Cancer Trial in France (Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, Panitumumab, oxaliplatin,

Recruiting
  • Metastatic Colorectal Cancer
  • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil
  • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, irinotecan
  • Avignon, France
  • +5 more
Aug 2, 2022

Pancreatic Adenocarcinoma Trial in Palo Alto (procedure, biological, drug)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Fluorescence Imaging
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jun 21, 2022

Brain Tumor Trial in Stanford (Panitumumab-IRDye800, Pinpoint-IR9000 endoscopic/handheld device, Explorer Air camera)

Not yet recruiting
  • Brain Tumor
  • Stanford, California
    Stanford Cancer Center
Nov 9, 2022

Colorectal Cancer Trial in Pisa (Regorafenib, Panitumumab)

Recruiting
  • Colorectal Cancer
  • Pisa, PI, Italy
    U.O. Oncologia 2 Universitaria
Aug 3, 2022

Pancreas Cancer Trial in Stanford (89Zr-panitumumab)

Suspended
  • Pancreas Cancer
  • Stanford, California
    Stanford University
Jun 15, 2022

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (drug, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jul 13, 2023

Lung Carcinoma, Metastatic Malignant Tumor in the Lung, Stage IV Lung Cancer AJCC v8 Trial in Palo Alto (procedure, drug, other)

Active, not recruiting
  • Lung Carcinoma
  • +4 more
  • Near-Infrared Fluorescence Imaging
  • +3 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jun 21, 2022

Head-and-neck Squamous Cell Carcinoma Trial in San Francisco (89Zr-panitumumab IV, Panitumumab)

Not yet recruiting
  • Head-and-neck Squamous Cell Carcinoma
  • 89Zr-panitumumab IV
  • Panitumumab
  • San Francisco, California
    Stanford Cancer Institute
Jun 14, 2022

Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)

Completed
Has Results
  • Breast Cancer
  • Panitumumab
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 20, 2022

Metastatic Colorectal Cancer Trial in Berlin (Panitumumab 20 milligram/ML, Bevacizumab, Trifluridine/Tipiracil Hydrochloride)

Recruiting
  • Metastatic Colorectal Cancer
  • Panitumumab 20 milligram/ML
  • +2 more
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin
Jul 20, 2022

Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV Trial in Chicago

Recruiting
  • Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
  • +2 more
  • Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab
  • Chicago, Illinois
    Northwestern University
Nov 16, 2022

EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

Recruiting
  • EGFR NP_005219.2:p.S492R
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Colorectal Cancer Stage IV Trial in Napoli (Panitumumab)

Completed
  • Colorectal Cancer Stage IV
  • Panitumumab
  • Napoli, Italy
    Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pasc
Apr 6, 2022

Colorectal Cancer Trial in Madrid (FOLFOX regimen, Panitumumab, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • FOLFOX regimen
  • +3 more
  • Madrid, Spain
    Spanish Cooperative Group for the Treatment of Digestive Tumors
Mar 8, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (procedure, biological, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • (no location specified)
Dec 2, 2022

Head Neck Cancer Trial in Stanford (111I-n panitumumab, Single photon emission computed tomography/computed tomography

Recruiting
  • Head and Neck Cancer
  • 111I-n panitumumab
  • Single photon emission computed tomography/computed tomography (SPECT/CT) scans
  • Stanford, California
    Stanford University
Mar 11, 2022

Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 12, 2022

Metastatic Colorectal Cancer Trial in Mecca (Panitumumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Panitumumab
  • Mecca, Makkah Western, Saudi Arabia
    King Abdullah Medical City, Holy Capital
Apr 5, 2022

Head Neck Cancer Trial in Birmingham (Panitumumab-IRDye800)

Recruiting
  • Head and Neck Cancer
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 12, 2021

Metastatic Colon Cancer Trial in Italy (Trifluridine Tipiracil, Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX])

Completed
  • Metastatic Colon Cancer
  • Trifluridine Tipiracil
  • Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX]
  • Monserrato, CA, Italy
  • +7 more
Jul 21, 2022

Metastatic Colorectal Cancer Trial in United States (panitumumab, Randomization to No Panitumumab)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • panitumumab
  • Randomization to No Panitumumab
  • Basking Ridge, New Jersey
  • +7 more
Apr 1, 2022

Colorectal Cancer, Metastatic Colorectal Cancer, RAS Wild Type Colorectal Cancer Trial in Nashville (drug, biological, other,

Recruiting
  • Colorectal Cancer
  • +3 more
  • Glutaminase Inhibitor CB-839
  • +5 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Mar 29, 2022